61. Accurate non‐invasive diagnosis and staging of non‐alcoholic fatty liver disease using the urinary steroid metabolome. Issue 11 (16th April 2020) Authors: Moolla, Ahmad; de Boer, Jasper; Pavlov, David; Amin, Amin; Taylor, Angela; Gilligan, Lorna; Hughes, Beverly; Ryan, John; Barnes, Eleanor; Hassan‐Smith, Zaki; Grove, Jane; Aithal, Guruprasad P.; Verrijken, An; Francque, Sven; Van Gaal, Luc; Armstrong, Matthew J.; Newsome, Phillip N.; Cobbold, Jere... Journal: Alimentary pharmacology & therapeutics Issue: Volume 51:Issue 11(2020) Page Start: 1188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
62. Acid suppression medications reduce risk of oesophageal adenocarcinoma in Barrett's oesophagus: a nested case‐control study in US male veterans. Issue 4 (29th June 2018) Authors: Tan, M. C.; El‐Serag, H. B.; Yu, X.; Thrift, A. P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 48:Issue 4(2018) Page Start: 469 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
63. Acid‐inhibitory effects of vonoprazan 20 mg compared with esomeprazole 20 mg or rabeprazole 10 mg in healthy adult male subjects ‐ a randomised open‐label cross‐over study. Issue 6 (21st July 2015) Authors: Sakurai, Y.; Mori, Y.; Okamoto, H.; Nishimura, A.; Komura, E.; Araki, T.; Shiramoto, M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 42:Issue 6(2015) Page Start: 719 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
64. Acute gastrointestinal bleeding: proposed study outcomes for new randomised controlled trials. Issue 5 (20th July 2021) Authors: Jensen, Dennis M.; Barkun, Alan; Cave, David; Gralnek, Ian M.; Jutabha, Rome; Laine, Loren; Lau, James Y. W.; Saltzman, John R.; Soetikno, Roy; Sung, Joseph J. Y. Journal: Alimentary pharmacology & therapeutics Issue: Volume 54:Issue 5(2021) Page Start: 616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
65. Acute liver failure in Scotland: changes in aetiology and outcomes over time (the Scottish Look‐Back Study). Issue 6 (18th January 2017) Authors: Donnelly, M. C.; Davidson, J. S.; Martin, K.; Baird, A.; Hayes, P. C.; Simpson, K. J. Journal: Alimentary pharmacology & therapeutics Issue: Volume 45:Issue 6(2017) Page Start: 833 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
66. Adalimumab dose escalation is effective for managing secondary loss of response in Crohn's disease. Issue 9 (3rd September 2014) Authors: Ma, C.; Huang, V.; Fedorak, D. K.; Kroeker, K. I.; Dieleman, L. A.; Halloran, B. P.; Fedorak, R. N. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 9(2014) Page Start: 1044 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
67. Adalimumab drug and antibody levels as predictors of clinical and laboratory response in patients with Crohn's disease. Issue 6 (15th July 2014) Authors: Mazor, Y.; Almog, R.; Kopylov, U.; Ben Hur, D.; Blatt, A.; Dahan, A.; Waterman, M.; Ben‐Horin, S.; Chowers, Y. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 6(2014) Page Start: 620 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
68. Adalimumab in Crohn's disease patients: pharmacokinetics in the first 6 months of treatment. Issue 10 (28th September 2014) Authors: Lie, M. R. K. L.; Peppelenbosch, M. P.; West, R. L.; Zelinkova, Z.; van der Woude, C. J. Journal: Alimentary pharmacology & therapeutics Issue: Volume 40:Issue 10(2014) Page Start: 1202 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
69. Adalimumab maintains remission of Crohn's disease after up to 4 years of treatment: data from CHARM and ADHERE. Issue 10 (22nd September 2013) Authors: Panaccione, R.; Colombel, J.‐F.; Sandborn, W. J.; D'Haens, G.; Zhou, Q.; Pollack, P. F.; Thakkar, R. B.; Robinson, A. M. Journal: Alimentary pharmacology & therapeutics Issue: Volume 38:Issue 10(2013) Page Start: 1236 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
70. Adalimumab or infliximab as monotherapy, or in combination with an immunomodulator, in the treatment of Crohn's disease. Issue 10 (26th September 2016) Authors: Cosnes, J.; Sokol, H.; Bourrier, A.; Nion‐Larmurier, I.; Wisniewski, A.; Landman, C.; Marteau, P.; Beaugerie, L.; Perez, K.; Seksik, P. Journal: Alimentary pharmacology & therapeutics Issue: Volume 44:Issue 10(2016) Page Start: 1102 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗